Bluegrass Vascular, founded by John Gurley, M.D., is dedicated to developing innovative lifesaving devices and methods that address limitations with current vascular access procedures.
The Current Situation
Limited Vascular Access
Many patients rely on permanent vascular access to receive vital therapies such as hemodialysis, chemotherapy and nutrition. While permanent access can take 4 months to mature, hemodialysis patients receive therapy via a central venous catheter (CVC).
40% of patients who receive CVCs can develop a venous obstruction1. The current approach is to move to another central vein for CVC placement, often increasing patient morbidity and the cost of care1.
Restore Vein Access
Bluegrass Vascular has developed a unique approach to reliably and repeatedly restore access, which avoids using other veins. Our approach is designed to improve patient outcomes and reduce the cost of care1.
Introducing the unique, minimally invasive Surfacer® Inside-Out® Access Catheter System.